Why Biotechs And Emerging Pharma Trust Novotech

Novotech is a full-service clinical research organization (CRO) offering integrated laboratory services, Phase 1 clinical trial facilities, drug development consulting, and deep FDA regulatory expertise. With experience spanning more than 5,000 clinical projects—including Phase 1 through Phase 4 trials and bioequivalence studies — Novotech supports biotech and pharmaceutical sponsors across the entire development lifecycle.

The company is strategically positioned to conduct and manage clinical trials throughout the Asia Pacific, the United States, and Europe, combining global reach with strong regional knowledge. Backed by a global team of more than 3,000 professionals across 34 office locations, Novotech delivers scalable, high-quality clinical development solutions tailored to the needs of emerging and mid-sized biotech companies.